Skip to main content
logo
Kestra Medical Technologies, Ltd. (KMTS)
NASDAQ: KMTS · Real-Time Price · USD
21.57
+0.68 (3.26%)
Jul 23, 2026, 4:00 PM EDT - Market closed

KMTS Financials Overview

Millions USD. Fiscal year is May - Apr.

Revenue & Profits
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2021
Period EndingApr '26 Apr '26 Apr '25 Apr '24 Apr '23 Apr '21
Revenue
95.1395.1359.8227.817.63-
Revenue Growth
59.03%59.03%115.05%264.54%--
Gross Profit
48.8648.8624.210.36-10.65-
Operating Income
-134.74-134.74-106.38-85.06-80.42-32.71
Net Income
-131.61-131.61-126.14-100.84-86.74-34.1
Earnings Per Share
-2.43-2.43-5.13-5.07-820.00-
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2021FY 2020
Period EndingApr '26 Apr '26 Apr '25 Apr '24 Apr '21 Apr '20
Cash & Investments
196.43196.43237.68.2524.345.76
Total Debt
46.7946.7944.3145.1722.850.45
Net Cash (Debt)
149.64149.64193.28-36.921.495.3
Net Cash Growth
-22.58%-22.58%---71.85%-
Net Cash Per Share
2.762.767.86-1.86--

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2021
Period EndingApr '26 Apr '26 Apr '25 Apr '24 Apr '23 Apr '21
Operating Cash Flow
-81.7-81.7-77.61-72.24-69.64-29.9
Capital Expenditures
-34.89-34.89-22.94-12.23--0.34
Free Cash Flow
-116.6-116.6-100.54-84.46-69.64-30.23
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2021
Period EndingApr '26 Apr '26 Apr '25 Apr '24 Apr '23 Apr '21
Gross Margin
51.37%51.37%40.47%1.30%-139.59%-
Operating Margin
-141.65%-141.65%-177.84%-305.83%-1054.01%-
Pretax Margin
-138.05%-138.05%-190.05%-338.30%-1103.84%-
Profit Margin
-138.36%-138.36%-190.28%-338.39%-1104.04%-
FCF Margin
-122.57%-122.57%-168.09%-303.66%-912.74%-

Valuation
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2021
Period EndingJul '26 Apr '26 Apr '25 Apr '24 Apr '23 Apr '21
PS Ratio
13.2912.7220.65---